Senior insider sale
CFO, Treasurer and Secretary at ORAMED PHARMACEUTICALS INC. — senior position signals high conviction
$424.1K
93.36K shares
What this filing means
GABAY AVRAHAM plans to sell 93.36K shares of ORAMED PHARMACEUTICALS INC. valued at approximately $424.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2026ACC: 0001976408-26-000877
Officer· CFO, Treasurer and Secretary
Since Jun 2019
93.36K
Shares to sell
$424.1K
Approx. market value
105.03K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Shares issued upon vesting of RSUs
No consideration, shares issued upon vesting of RSUs
6/18/2026
105.03KTotal acquired105.03K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/18/2026 | Shares issued upon vesting of RSUs No consideration, shares issued upon vesting of RSUs | 105.03K | — |
| Total | 105.03K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
73.36K
Market value
$330.7K
7/1/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
20K
Market value
$93.4K
10/1/2026
Total
Units
93.36K
Value
$424.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2026 | 73.36K | $330.7K | — | Completed |
| Planned — Approximate Date | ||||
10/1/2026 | 20K | $93.4K | Nasdaq | Planned |
| Total | 93.36K | $424.1K | ||